YOU ARE HERE:
Lipodystrophy news
page  of 9
 
Headline
Date
  Antiretroviral drugs have variable effects on bones and fat, lipoatrophy uncommon with modern regimens
21.02.10
  Tesamorelin safe and effective for fat accumulation in patients taking HIV treatment
03.02.10
  Genetic marker predicts fat loss due to d4T in Thai patients
26.01.10
  Cardiovascular risks common amongst young US women with HIV
11.01.10
  Erectile dysfunction common in men with HIV, PIs a cause
03.12.09
  Cosmetic treatment for facial fat loss safe and effective in the long term
27.04.09
  Body-shape changes and lipid abnormalities common in HIV-positive children and young adults
19.03.09
  Rosiglitazone improves fat loss and insulin resistance in people with lipoatrophy
12.02.09
  Study suggests that HIV infection and use of antiretroviral therapy both can have negative effects on arteries
28.01.09
  US Latinos have more unfavourable metabolic and body fat changes on HIV drugs
16.01.09
  Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
02.01.09
  Portable lactate test is reliable and accurate
19.12.08
  Exercise intolerance may be due to impact of HIV treatment on heart
05.12.08
  Ezetimibe safe and effective for cholesterol reduction in patients taking HIV treatment
24.09.08
  Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries
19.08.08
  Long-term HIV treatment cuts risk of hardening of coronary artery
19.08.08
  Lipodystrophy common, but does not affect adherence in Thai patients
04.08.08
  Switch to atazanavir does not reduce belly fat
04.08.08
  Fatty liver in patients with HIV associated with metabolic abnormalities
03.07.08
  Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV
01.07.08

page  of 9